BioCryst Pharmaceuticals Inc - Seeks to Block FDA Approval of Generic Orladeyo Until Patent Expiration
BioCryst製藥公司 - 尋求阻止FDA批准仿製Orladeyo,直到專利到期
BioCryst Pharmaceuticals Inc - Seeks to Block FDA Approval of Generic Orladeyo Until Patent Expiration
BioCryst製藥公司 - 尋求阻止FDA批准仿製Orladeyo,直到專利到期
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因